Recently, the microbiome — the collection of microorganisms that live on and within our bodies — has been implicated as playing a role in a wide variety of diseases. The intestinal microbiome can modulate the immune system, resulting in a beneficial or detrimental effect on neurologic diseases. It is increasingly clear that the molecular interactions between the gut microbiome and the central nervous system (CNS) play a key role in regulating neural function and CNS inflammation through a gut-brain axis. Recent work shows that the microbiota can drive neurodegeneration in models of Alzheimer’s, Parkinson’s, and MS.

Doctors from the Ann Romney Center for Neurologic Diseases recently published an exciting new study in Nature on the gut-brain connection, specifically how the gut influences neurologic diseases. Their work “defines a pathway that may help guide therapies for multiple sclerosis and other neurologic diseases.”

Check out this article on Medical Xpress to learn more.